Pieter C Goeminne1, Jennifer Vandooren2, Eva A Moelants2, Ann Decraene1, Evelyn Rabaey3, Ans Pauwels4, Sven Seys5, Ghislain Opdenakker2, Paul Proost2, Lieven J Dupont1. 1. Department of Respiratory Disease, University Hospital of Gasthuisberg, Leuven, Belgium. 2. Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, Leuven, Belgium. 3. Department of Radiology, University Hospital of Gasthuisberg, Leuven, Belgium. 4. Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium. 5. Laboratory of Clinical Immunology, Catholic University of Leuven, Leuven, Belgium.
Abstract
BACKGROUND AND OBJECTIVE: Non-cystic fibrosis bronchiectasis (NCFB) is characterized by a vicious cycle of airway infection, inflammation and structural damage with inappropriate mucus clearance. Our aim was to relate the value of proteolytic enzymes, proteolytic enzyme activity and inflammatory markers to disease severity and symptoms in patients with NCFB. METHODS: Sputum induction in NCFB patients and healthy controls was performed. Sputum was analysed for total and differential cell count, markers of inflammation (CXCL8 (also known as interleukin-8) and tumour necrosis factor-α (TNF-α)) and proteolytic enzymes (neutrophil elastase (NE), gelatin zymography and total gelatinolytic activity (TGA)). Each patient was evaluated by spirometry, Leicester Cough Questionnaire (LCQ) and Sputum Colour Chart (SCC). Patient files were analysed to determine Pseudomonas aeruginosa colonization status. The computed tomography (CT) closest to the date sputum induction was scored by a radiologist. RESULTS: NCFB patients showed significantly higher neutrophils, CXCL8, TNF-α, NE and TGA than healthy controls. TGA subanalysis showed that the majority of the activity was NE (82 ± 6.4%). Residual activity was mainly zinc ion-dependent matrix metalloproteinase (MMP) activity (18 ± 6.4%). Subanalysis showed that patients with chronic Pseudomonas aeruginosa colonization had more activated MMP-9. Correlations were seen between proteolytic enzymes and inflammation and disease severity (spirometry and CT score), but not with the LCQ. SCC was associated with increased markers of inflammation, proteolytic enzymes and worse CT score. CONCLUSIONS: We show that sputum purulence assessment in daily clinical practice using the SCC is a quick and easy tool that reflects severity of inflammation, destruction and proteolytic enzymatic activity/presence.
BACKGROUND AND OBJECTIVE:Non-cystic fibrosis bronchiectasis (NCFB) is characterized by a vicious cycle of airway infection, inflammation and structural damage with inappropriate mucus clearance. Our aim was to relate the value of proteolytic enzymes, proteolytic enzyme activity and inflammatory markers to disease severity and symptoms in patients with NCFB. METHODS: Sputum induction in NCFB patients and healthy controls was performed. Sputum was analysed for total and differential cell count, markers of inflammation (CXCL8 (also known as interleukin-8) and tumour necrosis factor-α (TNF-α)) and proteolytic enzymes (neutrophil elastase (NE), gelatin zymography and total gelatinolytic activity (TGA)). Each patient was evaluated by spirometry, Leicester Cough Questionnaire (LCQ) and Sputum Colour Chart (SCC). Patient files were analysed to determine Pseudomonas aeruginosa colonization status. The computed tomography (CT) closest to the date sputum induction was scored by a radiologist. RESULTS: NCFB patients showed significantly higher neutrophils, CXCL8, TNF-α, NE and TGA than healthy controls. TGA subanalysis showed that the majority of the activity was NE (82 ± 6.4%). Residual activity was mainly zinc ion-dependent matrix metalloproteinase (MMP) activity (18 ± 6.4%). Subanalysis showed that patients with chronic Pseudomonas aeruginosa colonization had more activated MMP-9. Correlations were seen between proteolytic enzymes and inflammation and disease severity (spirometry and CT score), but not with the LCQ. SCC was associated with increased markers of inflammation, proteolytic enzymes and worse CT score. CONCLUSIONS: We show that sputum purulence assessment in daily clinical practice using the SCC is a quick and easy tool that reflects severity of inflammation, destruction and proteolytic enzymatic activity/presence.
Authors: James D Chalmers; Kelly L Moffitt; Guillermo Suarez-Cuartin; Oriol Sibila; Simon Finch; Elizabeth Furrie; Alison Dicker; Karolina Wrobel; J Stuart Elborn; Brian Walker; S Lorraine Martin; Sara E Marshall; Jeffrey T-J Huang; Thomas C Fardon Journal: Am J Respir Crit Care Med Date: 2017-05-15 Impact factor: 21.405
Authors: Sally Spencer; Lambert M Felix; Stephen J Milan; Rebecca Normansell; Pieter C Goeminne; James D Chalmers; Tim Donovan Journal: Cochrane Database Syst Rev Date: 2018-03-27
Authors: Federico L Dente; Marta Bilotta; Maria Laura Bartoli; Elena Bacci; Silvana Cianchetti; Manuela Latorre; Laura Malagrinò; Dario Nieri; Maria Adelaide Roggi; Barbara Vagaggini; Pierluigi Paggiaro Journal: Mediators Inflamm Date: 2015-12-27 Impact factor: 4.711
Authors: James D Chalmers; Megan Crichton; Pieter C Goeminne; Michael R Loebinger; Charles Haworth; Marta Almagro; Montse Vendrell; Anthony De Soyza; Raja Dhar; Lucy Morgan; Francesco Blasi; Stefano Aliberti; Jeanette Boyd; Eva Polverino Journal: Breathe (Sheff) Date: 2017-09
Authors: A Padilla-Galo; C Olveira; L Fernández de Rota-Garcia; I Marco-Galve; A J Plata; A Alvarez; F Rivas-Ruiz; A Carmona-Olveira; J J Cebrian-Gallardo; M A Martinez-Garcia Journal: Respir Res Date: 2018-03-16